Skip to Main Content
TRC_PL_NEW
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Journal Club
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: We have made updates to the logos on our site. This will not impact access to your subscription.
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment

Treatment

  • Diabetes (898)
    • Blood Glucose Meters (9)
    • Complications (201)
    • Diabetes in Pregnancy (12)
    • Diabetes Meds (83)
    • Drug-Induced Hypo/Hyperglycemia (140)
    • Monitoring (139)
    • Natural Medicines/Supplements (9)
    • Prevention (47)
    • Treatment (371)
      • Alpha-Glucosidase Inhibitors (27)
      • Amylin Agonist (20)
      • Bromocriptine (10)
      • Combination Products (23)
      • Gliptins (85)
      • Glitazones (129)
      • GLP-1 (41)
      • Incretin Enhancers/Mimetics (82)
      • Insulin (197)
      • Meglitinides (46)
      • Metformin (165)
      • SGLT2 Inhibitors (86)
      • Sulfonylureas (131)
      • Treatment of Pediatric Metabolic Syndrome (10)
  • Endocrinology (9)
  • Hyperglycemia (39)
  • Hypoglycemia (19)
  • Other (31)
  • Prediabetes (5)
  • Resources (277)
  • Thyroid Disorders (63)
166 - 180 of 371 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
PL Voices: Helping Patients Stick with Metformin December 2015
Article: Consider Avoiding Canagliflozin (Invokana) in Patients at Risk of Fractures December 2015
Article: Help Patients Give Metformin a Fair Chance December 2015
Commentary: Canagliflozin (Invokana, Invokamet) Bone Fracture Risk December 2015
Article: Consider NPH and Regular Insulin INSTEAD of Insulin Analogs November 2015
Article: Don't be too Quick to Jump on the Jardiance (empagliflozin) Bandwagon November 2015
PL Voices: Cardiovascular Outcomes with Empagliflozin (Jardiance) November 2015
PL Voices: Insulin Analogs versus Human Insulin November 2015
Commentary: Empagliflozin and Cardiovascular Disease November 2015
Chart: How to Switch Insulin Products November 2015
Article: Listen for Gliptin Patients Complaining of Severe Joint Pain October 2015
Article: Watch for Hypoglycemia in Patients Taking Repaglinide Plus Clopidogrel October 2015
Other: Adverse Event Reporting Program October 2015
Commentary: DPP-4 Inhibitors (Gliptins) and Severe Joint Pain October 2015
Article: Don't Recommend Gliptins to Manage Prediabetes August 2015
  • « Prev
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved